Developer docs
API playgroundTry for free, no card

Search company profiles

Tyromotion

Full company profile

uuid0008i3z

Namestring
Tyromotion
Legal namestring
Tyromotion GmbH
Websiteurl
tyromotion.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Tyromotion GmbH, founded in 2007 and headquartered in Graz, Austria, manufactures and distributes mechatronic, robotic, and sensor-based rehabilitation devices for neurorehabilitation and physical therapy. The company serves hospitals, rehabilitation clinics, geriatric and pediatric facilities, and academic medical centers across Europe (Austria, Germany, UK, France, Italy, Hungary, Croatia, Lithuania) and North America, with a wholly-owned US sales subsidiary (Tyromotion Inc) in Marietta, Georgia. Tyromotion employs 100+ people and has trained 5,000 therapists worldwide through its TyroAcademy platform as of October 2025.

The product portfolio is organized into upper extremity (Amadeo, Diego, Myro, Pablo), lower extremity (Lexo, Omego Plus, Tymo), medical training therapy (MTT-Line), and the newly launched Elvis standing and balance therapy system, supported by the Tyrostation accessory and two software platforms: TyroS, which connects and manages all devices with gamification, and Maya, which standardizes therapy documentation and reporting. Underlying technology combines proprietary mechatronic engineering, robotics, force/position sensors, and integrated software; the company received EU MDR (Medical Device Regulation) certification in December 2025.

Tyromotion generates revenue through three streams: (1) hardware sales of rehabilitation devices via quote-based custom pricing to healthcare facilities, (2) software licensing for TyroS and Maya, and (3) professional services including TyroAcademy training, installation, and ongoing support. The go-to-market is direct enterprise sales with regional offices, complemented by participation in major rehabilitation conferences (Therapie München, AACPDM, AMPRA), on-site workshops at customer facilities, and digital marketing. The company is privately held and founder-influenced, with CTO Alexander Kollreider, CSO Wolfram Veitl (joined February 2020), and strategic advisor/co-founder David Ram; SHS Capital is the only known institutional investor from a 2016 funding round.

Short descriptiontext

Tyromotion GmbH, founded in 2007 in Graz, Austria, manufactures robotic and sensor-based rehabilitation devices for neurorehabilitation, serving hospitals, rehabilitation clinics, and academic medical centers globally through direct enterprise sales and integrated therapy software platforms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersGraz, Austria
HQ citystring
Graz
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rehabilitation robotics, neurorehabilitation devices, robotic therapy systems, medical training therapy, therapy software platforms
Industry3 codes
1Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
CodeHLAHAMAGPrimaryYes
2Hand & Upper Extremity Therapy (OT/CHT)
CodeHSADAIAHPrimaryNo
3Digital Rehabilitation & Physical Therapy Therapeutics
CodeHLACANAJPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Rehabilitation Robotics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Rehabilitation Hardware Devices
TypeHardware Sales
Description

Sale of mechatronic rehabilitation devices including gait trainers, therapy robots, and medical training equipment for hospitals, clinics, and rehabilitation centers

tyromotion.com
2Software Licensing
TypeLicensing Royalties
Description

Licensing of TyroS and Maya therapy software platforms for documentation, assessment, and device management

tyromotion.com
3Professional Services and Training
TypeProfessional Services
Description

Training services through TyroAcademy, installation, and ongoing support services for customers

tyromotion.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1TyroTherapy
Description

Integrated therapy concept combining Tyromotion rehabilitation devices including Amadeo, Diego, Myro, Pablo, Tymo, and Lexo for comprehensive neurorehabilitation treatment.

tyromotion.com
+3 more records
Core offering1 text field

Tyromotion manufactures and distributes mechatronic robotic and sensor-based therapy devices for neurological and orthopedic rehabilitation, including finger-hand, shoulder-arm, gait, balance, and medical training therapy systems. The product portfolio is complemented by integrated software platforms (Maya and TyroS) that standardize documentation, track patient progress, and unify device management across rehabilitation facilities. Products are EU MDR-certified medical devices sold primarily to hospitals, clinics, and academic medical centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 5,000 therapists trained worldwide through TyroAcademy
Product overview1 text field

Tyromotion is a global manufacturer of technology-assisted rehabilitation and therapy devices based in Graz, Austria. The product portfolio consists of robotic and sensor-based rehabilitation devices organized into upper extremity (Amadeo, Diego, Myro, Pablo), lower extremity (Lexo, Omego Plus, Tymo), and medical training therapy (MTT-Line) categories, supported by software platforms (Maya therapy platform, TyroS integrated software) and accessory systems (Tyrostation). The devices are connected through the Maya platform for unified documentation and reporting. Tyromotion also recently launched Elvis, a new standing and balance therapy system. The portfolio serves neurological and orthopedic rehabilitation across acute to chronic phases for patients with conditions including stroke, Parkinson's disease, multiple sclerosis, and spinal cord injuries.

Product and service1 record
1Amadeo
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

MOTIONrehab, a multidisciplinary neurological rehabilitation center in the UK, uses Tyromotion technology including robotic therapy devices. MOTIONrehab was recognized by Google Europa and Financial Times as one of Europe's top 100 digital innovators.

2International Conference on Rehabilitation Robotics / Indonesian Association
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration to expand regional access to rehabilitation robotics technology in Indonesia and the Asia-Pacific region.

tyromotion.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Now part of DIH, Hocoma is the most established direct competitor to Tyromotion, offering the Lokomat gait robot, Armeo power-assisted arm/hand therapy devices, and Erigo standing systems — the closest product-line overlap in neurorehabilitation robotics.

TypeDirect peer
Description

Bionik offers the InMotion ARM and InMotion HAND robotic therapy systems for upper-extremity rehabilitation, directly competing with Tyromotion's Amadeo, Pablo, and Diego product lines in the same clinical use cases and customer segments.

TypeDirect peer
Description

Motek specializes in gait and balance analysis/rehabilitation systems (CAREN, M-Gait, N-Mill) and is a direct competitor to Tyromotion's Lexo gait trainer and Tymo balance/assessment platform in research and clinical rehab settings.

TypeEmerging player
Description

Saebo makes upper-extremity rehabilitation devices (SaeboGlove, SaeboReach, SaeboStim) for stroke survivors. It competes with Tyromotion's Amadeo and Pablo in the same hand/arm rehab indication but with a more consumer/clinic-channel mix and lower price points.

TypeBroad incumbent
Description

Ekso Bionics develops wearable robotic exoskeletons (EksoNR, Ekso Indego) for gait rehabilitation. It competes indirectly with Tyromotion's Lexo and Omego Plus in the gait-rehabilitation indication but is best known for wearable over stationary robotics.

TypeBroad incumbent
Description

Bioness offers functional electrical stimulation (FES) and rehabilitation technology (L300 Go, H200 Wireless) for foot drop and hand paralysis. It overlaps with Tyromotion's neurological rehabilitation use cases but is more focused on stimulation than robotic mechatronics.

TypeEmerging player
Description

Aretech manufactures the ZeroG Gait and Balance System for overground body-weight-supported gait training. It competes with Tyromotion's Lexo in robotic gait rehabilitation, particularly in US hospitals and rehabilitation centers.

TypeEmerging player
Description

Fourier Intelligence builds rehabilitation robotics (ArmMotus M2 Pro, ExoMotus X1, RehabHub) spanning upper and lower extremity therapy. It is an emerging global player, particularly strong in Asia-Pacific, with overlapping product categories to Tyromotion's portfolio.

TypeEmerging player
Description

ReWalk develops wearable exoskeletons (ReWalk Personal, ReStore) for stroke and spinal cord injury rehabilitation. It is a partial peer, competing with Tyromotion in gait and lower-extremity rehabilitation but with a wearable rather than stationary-device approach.

TypeBroad incumbent
Description

Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology. While not a direct competitor to Tyromotion's robotics portfolio, Ottobock competes broadly for the same hospital and rehabilitation-center budgets and is a strategic reference point in the neuro-rehab market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tyromotion

Rehabilitation Roboticstyromotion.com

Tyromotion GmbH, founded in 2007 in Graz, Austria, manufactures robotic and sensor-based rehabilitation devices for neurorehabilitation, serving hospitals, rehabilitation clinics, and academic medical centers globally through direct enterprise sales and integrated therapy software platforms.

What Tyromotion does

Tyromotion GmbH, founded in 2007 and headquartered in Graz, Austria, manufactures and distributes mechatronic, robotic, and sensor-based rehabilitation devices for neurorehabilitation and physical therapy. The company serves hospitals, rehabilitation clinics, geriatric and pediatric facilities, and academic medical centers across Europe (Austria, Germany, UK, France, Italy, Hungary, Croatia, Lithuania) and North America, with a wholly-owned US sales subsidiary (Tyromotion Inc) in Marietta, Georgia. Tyromotion employs 100+ people and has trained 5,000 therapists worldwide through its TyroAcademy platform as of October 2025.

The product portfolio is organized into upper extremity (Amadeo, Diego, Myro, Pablo), lower extremity (Lexo, Omego Plus, Tymo), medical training therapy (MTT-Line), and the newly launched Elvis standing and balance therapy system, supported by the Tyrostation accessory and two software platforms: TyroS, which connects and manages all devices with gamification, and Maya, which standardizes therapy documentation and reporting. Underlying technology combines proprietary mechatronic engineering, robotics, force/position sensors, and integrated software; the company received EU MDR (Medical Device Regulation) certification in December 2025.

Tyromotion generates revenue through three streams: (1) hardware sales of rehabilitation devices via quote-based custom pricing to healthcare facilities, (2) software licensing for TyroS and Maya, and (3) professional services including TyroAcademy training, installation, and ongoing support. The go-to-market is direct enterprise sales with regional offices, complemented by participation in major rehabilitation conferences (Therapie München, AACPDM, AMPRA), on-site workshops at customer facilities, and digital marketing. The company is privately held and founder-influenced, with CTO Alexander Kollreider, CSO Wolfram Veitl (joined February 2020), and strategic advisor/co-founder David Ram; SHS Capital is the only known institutional investor from a 2016 funding round.

Tyromotion firmographics

Firmographics
Name
Tyromotion
Legal name
Tyromotion GmbH
Website
https://tyromotion.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Short description
Tyromotion GmbH, founded in 2007 in Graz, Austria, manufactures robotic and sensor-based rehabilitation devices for neurorehabilitation, serving hospitals, rehabilitation clinics, and academic medical centers globally through direct enterprise sales and integrated therapy software platforms.
Ownership category
akta.pro rank

Tyromotion industry classification

Industry
Product category
Rehabilitation Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
akta.pro secondary industries
Hand & Upper Extremity Therapy (OT/CHT) (HSADAIAH), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ)

Keywords

  • Rehabilitation robotics
  • Neurorehabilitation devices
  • Robotic therapy systems
  • Medical training therapy
  • Therapy software platforms

Where Tyromotion is headquartered

Location

Headquarters

HQ city
Graz
HQ country
Austria
HQ region
Europe

Offices2 records

Markets served

Tyromotion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Rehabilitation Hardware Devices: Sale of mechatronic rehabilitation devices including gait trainers, therapy robots, and medical training equipment for hospitals, clinics, and rehabilitation centers
  2. Software Licensing: Licensing of TyroS and Maya therapy software platforms for documentation, assessment, and device management
  3. Professional Services and Training: Training services through TyroAcademy, installation, and ongoing support services for customers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Tyromotion product offering

Product offering

Core offering

Tyromotion manufactures and distributes mechatronic robotic and sensor-based therapy devices for neurological and orthopedic rehabilitation, including finger-hand, shoulder-arm, gait, balance, and medical training therapy systems. The product portfolio is complemented by integrated software platforms (Maya and TyroS) that standardize documentation, track patient progress, and unify device management across rehabilitation facilities. Products are EU MDR-certified medical devices sold primarily to hospitals, clinics, and academic medical centers.

Product overview

Tyromotion is a global manufacturer of technology-assisted rehabilitation and therapy devices based in Graz, Austria. The product portfolio consists of robotic and sensor-based rehabilitation devices organized into upper extremity (Amadeo, Diego, Myro, Pablo), lower extremity (Lexo, Omego Plus, Tymo), and medical training therapy (MTT-Line) categories, supported by software platforms (Maya therapy platform, TyroS integrated software) and accessory systems (Tyrostation). The devices are connected through the Maya platform for unified documentation and reporting. Tyromotion also recently launched Elvis, a new standing and balance therapy system. The portfolio serves neurological and orthopedic rehabilitation across acute to chronic phases for patients with conditions including stroke, Parkinson's disease, multiple sclerosis, and spinal cord injuries.

Differentiator

Problem solved

Functional benefit

Brands

  • TyroTherapy: Integrated therapy concept combining Tyromotion rehabilitation devices including Amadeo, Diego, Myro, Pablo, Tymo, and Lexo for comprehensive neurorehabilitation treatment.
  • TyroAcademy
  • TyroS
  • Maya

Products and services

  • Amadeo

Quantifiable outcome

  • 5,000 therapists trained worldwide through TyroAcademy

Companies that use Tyromotion

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles3 records

Tyromotion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

Tyromotion partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • MOTIONrehabcoreTechnology or IntegrationMOTIONrehab, a multidisciplinary neurological rehabilitation center in the UK, uses Tyromotion technology including robotic therapy devices. MOTIONrehab was recognized by Google Europa and Financial Times as one of Europe's top 100 digital innovators.
  • International Conference on Rehabilitation Robotics / Indonesian AssociationminorStrategic or Co-development PartnerCollaboration to expand regional access to rehabilitation robotics technology in Indonesia and the Asia-Pacific region.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Tyromotion competitors and assessment

Company assessment

Direct peers

  • Hocoma (DIH): Now part of DIH, Hocoma is the most established direct competitor to Tyromotion, offering the Lokomat gait robot, Armeo power-assisted arm/hand therapy devices, and Erigo standing systems — the closest product-line overlap in neurorehabilitation robotics.
  • Bionik Laboratories: Bionik offers the InMotion ARM and InMotion HAND robotic therapy systems for upper-extremity rehabilitation, directly competing with Tyromotion's Amadeo, Pablo, and Diego product lines in the same clinical use cases and customer segments.
  • Motek Medical (DIH): Motek specializes in gait and balance analysis/rehabilitation systems (CAREN, M-Gait, N-Mill) and is a direct competitor to Tyromotion's Lexo gait trainer and Tymo balance/assessment platform in research and clinical rehab settings.

Emerging players

  • Saebo: Saebo makes upper-extremity rehabilitation devices (SaeboGlove, SaeboReach, SaeboStim) for stroke survivors. It competes with Tyromotion's Amadeo and Pablo in the same hand/arm rehab indication but with a more consumer/clinic-channel mix and lower price points.
  • Aretech: Aretech manufactures the ZeroG Gait and Balance System for overground body-weight-supported gait training. It competes with Tyromotion's Lexo in robotic gait rehabilitation, particularly in US hospitals and rehabilitation centers.
  • Fourier Intelligence: Fourier Intelligence builds rehabilitation robotics (ArmMotus M2 Pro, ExoMotus X1, RehabHub) spanning upper and lower extremity therapy. It is an emerging global player, particularly strong in Asia-Pacific, with overlapping product categories to Tyromotion's portfolio.
  • ReWalk Robotics: ReWalk develops wearable exoskeletons (ReWalk Personal, ReStore) for stroke and spinal cord injury rehabilitation. It is a partial peer, competing with Tyromotion in gait and lower-extremity rehabilitation but with a wearable rather than stationary-device approach.

Broad incumbents

  • Ekso Bionics: Ekso Bionics develops wearable robotic exoskeletons (EksoNR, Ekso Indego) for gait rehabilitation. It competes indirectly with Tyromotion's Lexo and Omego Plus in the gait-rehabilitation indication but is best known for wearable over stationary robotics.
  • Bioness: Bioness offers functional electrical stimulation (FES) and rehabilitation technology (L300 Go, H200 Wireless) for foot drop and hand paralysis. It overlaps with Tyromotion's neurological rehabilitation use cases but is more focused on stimulation than robotic mechatronics.
  • Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology. While not a direct competitor to Tyromotion's robotics portfolio, Ottobock competes broadly for the same hospital and rehabilitation-center budgets and is a strategic reference point in the neuro-rehab market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Tyromotion social profiles

Digital presence

Tyromotion compliance and trust

Trust signal

Compliance1 record

Tyromotion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tyromotion leadership team

Management profile

Number of profiles

Profiles3 records

Tyromotion subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Tyromotion funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tyromotion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tyromotion

What does Tyromotion do?

Tyromotion manufactures and distributes mechatronic robotic and sensor-based therapy devices for neurological and orthopedic rehabilitation, including finger-hand, shoulder-arm, gait, balance, and medical training therapy systems. The product portfolio is complemented by integrated software platforms (Maya and TyroS) that standardize documentation, track patient progress, and unify device management across rehabilitation facilities. Products are EU MDR-certified medical devices sold primarily to hospitals, clinics, and academic medical centers.

Is Tyromotion a public or private company?

Tyromotion is a private company. It is classified as venture growth investor backed and is currently operating.

When was Tyromotion founded?

Tyromotion was founded in 2007. It employs 101 to 250 people.

Where is Tyromotion based?

Tyromotion is headquartered in Graz, Austria, in the Europe region.

How does Tyromotion make money?

Three revenue lines are on record. Rehabilitation Hardware Devices are the primary driver. The others are software Licensing and professional Services and Training.

Who are Tyromotion's main competitors?

Direct peers on record are Hocoma (DIH), Bionik Laboratories and Motek Medical (DIH). Emerging players are Saebo, Aretech, Fourier Intelligence and ReWalk Robotics. Broad incumbents are Ekso Bionics, Bioness and Ottobock.

Does Tyromotion have an API?

No public API is recorded for Tyromotion.

What industry is Tyromotion in?

Tyromotion's product category is Rehabilitation Robotics. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HSADAIAH, Hand & Upper Extremity Therapy (OT/CHT). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooRehabilitation Robots Market Analysis Report 2025-2030, Featuring Profiles of Tyromotion, Hocoma, Rex Bionics, Kinova, Rehab-Robotics, ReWalk Robotics, Ekso Bionics, Cyberdyne and Bionik LaboratoriesResearchAndMarkets.com added a 120-page report on the global rehabilitation robots market, covering type, extremity, end-use and regional forecasts through 2030. The market is estimated at USD 428 million in 2024 and USD 1.03 billion by 2030, a 15.2% CAGR. Lower-body exoskeletons and hospitals & clinics led 2024 shares, while Asia Pacific is expected to grow fastest.PR NewswireNeurorehabilitation Devices Market By Products, By Therapy Area and Segment Forecasts to 2024A market research report valued the global neurorehabilitation devices market at USD 915.1 million in 2015 and projects it will reach USD 3.2 billion by 2024, driven by the rising prevalence of neurological disorders such as stroke, multiple sclerosis, and Parkinson's disease affecting approximately 1 billion people globally. North America dominates the market, followed by Europe, while Asia Pacific is expected to grow at the highest CAGR due to improving healthcare infrastructure. Key players including Bioness, Medtronic, Hocoma AG, Ectron Ltd., and Tyromotion are focusing on product development and distribution collaborations, with Medtronic having received USFDA approval in February 2016 for its brain stimulation therapy to treat Parkinson's disease.PR NewswireResearch and Markets - $3.2 Billion Neurorehabilitation Devices Market 2016-2024: Key Players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and TyromotionResearch and Markets announced the addition of a market research report on the global neurorehabilitation devices market, estimating the market will grow from USD 915.1 million in 2015 to USD 3.2 billion by 2024. The growth is driven by increasing prevalence of neurological disorders, rising awareness of neurorehabilitation services, and consistent technological advancements leading to novel product commercialization. North America currently dominates the market, while Asia Pacific is growing at the highest CAGR due to increasing target population and improving healthcare infrastructure.PR NewswireNeurorehabilitation Devices Market By Products, By Therapy Area and Segment Forecasts to 2024The global neurorehabilitation devices market was valued at USD 915.1 million in 2015 and is projected to reach USD 3.2 billion by 2024, driven by the increasing prevalence of neurological disorders affecting approximately 1 billion people worldwide, including 15 million annual stroke cases and millions affected by multiple sclerosis and Parkinson's disease. North America currently dominates the market, while Asia Pacific is expected to grow at the highest CAGR due to expanding target populations and improving healthcare infrastructure. Key market players including Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion are pursuing strategic initiatives such as collaborations for novel product development and distribution network strengthening.